Learning power-hour session – Good clinical trial design: Inclusivity as axiom (SESS20)
Islander Ballroom E
Learning power-hour sessions
Information
As the consumer demand for clinical substantiation increases, the industry must respond accordingly. Not only must products and ingredients do what they claim, they must also reflect the population for which they are formulated. Trials should be designed to achieve measurable results. In this education session, a panel of clinical research experts will take the stage to discuss the requirement of inclusivity in trial design. They’ll cover the unique challenges of building bodies of research for specific populations and how trial design can best overcome those challenges.
This session is included with the purchase of an Expo Pass or an Expo Pass Plus.
Session survey
Use link below to access this sessions survey
Speakers
Douglas Kalman
Clinical associate professorNova Southeastern UniversityBarry Skillington
Chief Commercial OfficerAtlantia Clinical Trials Ltd.David Foreman
PresidentHerbal PharmacistErin Lewis
Scientific directorKGK Science Inc.Susan Hewlings
VP of research affairsRadicle ScienceDuffy Hayes (moderator)
Managing editorSupplySide Journals